What imaging modalities are recommended for evaluating heavy menstrual bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Imaging for Heavy Menstrual Bleeding

Combined transabdominal and transvaginal ultrasound with Doppler is the most appropriate initial imaging study for evaluating heavy menstrual bleeding. 1, 2

Initial Imaging Approach

Start with combined transabdominal and transvaginal ultrasound (TAUS + TVUS) with Doppler imaging as your first-line diagnostic test. 1, 2, 3

  • Transvaginal ultrasound provides superior resolution for evaluating the endometrium, with 90-99% sensitivity for detecting fibroids and 90% sensitivity/98% specificity for submucosal fibroids. 1, 3

  • Transabdominal ultrasound is essential when the uterus is significantly enlarged, when large subserosal/pedunculated fibroids are present, or when TVUS has limited field-of-view. 1

  • Doppler imaging is a standard component that helps differentiate vascular from nonvascular tissue and identifies peripheral vascular flow patterns characteristic of fibroids versus adenomyosis. 1

  • This combined approach allows assessment of endometrial thickness, identification of structural causes (fibroids, polyps, adenomyosis), and characterization of fibroid location, size, and number. 2, 4

When Initial Ultrasound is Inconclusive

If the uterus is incompletely visualized or the initial ultrasound is inconclusive, proceed to MRI of the pelvis without and with IV contrast. 1, 2

  • MRI is superior to ultrasound for visualizing the endometrium when ultrasound is limited and for diagnosing adenomyosis, which often coexists with fibroids. 1, 2

  • MRI excels at identifying and mapping fibroids including their size, number, location, vascularity, and characterization as classic, degenerated, cellular, or atypical. 1

  • Gadolinium-based IV contrast is preferred for identification of fibroid vascularity and other characteristics. 1

Special Circumstance: Suspected Polyp

If a polyp is suspected on the original ultrasound, perform sonohysterography instead of proceeding directly to MRI. 1, 2

  • Sonohysterography has 94% sensitivity and 81% specificity for diagnosing submucosal fibroids and allows better visualization of intracavitary lesions. 1, 2

  • This modality is highly sensitive for endometrial lesions and can distinguish between focal or diffuse pathology. 1

Ongoing Surveillance

For follow-up imaging when surveillance is appropriate, use transvaginal ultrasound with Doppler, transabdominal ultrasound, sonohysterography, or MRI with contrast. 1

  • These modalities are complementary and can be used to assess for presence and growth of endometrial pathology over time. 1

Critical Pitfalls to Avoid

Never rely on imaging alone in perimenopausal women—endometrial biopsy is essential even with normal imaging due to significantly increased endometrial cancer risk in this age group. 2

  • Endometrial cancer risk increases significantly in perimenopausal women, and bleeding should not be assumed to be due to perimenopause without thorough evaluation. 2

  • Sonohysterography cannot distinguish between benign endometrial pathology and endometrial cancer with high certainty, so endometrial sampling or hysteroscopy is recommended when pathology is suspected. 1

  • Do not miss coexisting adenomyosis, as it often coexists with fibroids and affects treatment success; MRI is more sensitive than ultrasound for this diagnosis. 2

  • Submucosal fibroids are most likely to cause heavy bleeding, so accurate characterization of fibroid location is crucial for treatment planning. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evaluation and Management of Heavy Menstrual Bleeding in Perimenopausal Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Transvaginal Ultrasound for the Diagnosis of Abnormal Uterine Bleeding.

Clinical obstetrics and gynecology, 2017

Related Questions

What is the appropriate management and evaluation for a 54-year-old female experiencing prolonged menstrual bleeding for two weeks?
What is the best management plan for a 34-year-old single mother with a body mass index (BMI) of 35.7, presenting with irregular periods, menorrhagia (heavy menstrual bleeding), and recurrent offensive vaginal odor, who has a history of recurrent thrush, early menopause in her family, and is experiencing hirsutism, weight gain, and hair thinning, with initial lab results showing normal thyroid function and hemoglobin A1c (HbA1c) levels?
In a 41‑year‑old woman with abnormal uterine bleeding (AUB) requesting contraception, what is the most appropriate investigation to perform before prescribing contraception?
In a 41-year-old woman seeking contraception with no abnormal uterine bleeding or menstrual irregularities, what is the most appropriate investigation before initiating contraception?
What is the best course of treatment for a patient with persistent heavy menstrual bleeding for 2 months?
What are the differential diagnoses for a patient with lung nodules, metastatic rectal adenocarcinoma, and pulmonary tuberculosis?
Which ligament is most commonly injured in an ankle sprain caused by hyperinversion of the foot?
What is the most commonly ordered vitamin D level by Primary Care Physicians (PCPs)?
What pain medications can be given to a patient with a subarachnoid hemorrhage?
What is the best alternative intravenous fluid (IVF) for this patient?
What are the recommended serum 25-hydroxyvitamin D (25(OH)D) levels for pediatric patients?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.